Vanda Pharmaceuticals Inc. (VNDA) Financials

VNDA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 648.4 million 103.5 million
2023-09-30 641.6 million 98.5 million
2023-06-30 641.7 million 101.8 million
2023-03-31 644.5 million 108.8 million

VNDA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -4.0 million 3.3 million
2023-09-30 -2.1 million 3.2 million
2023-06-30 -13.3 million 3.2 million
2023-03-31 31.8 million 4.4 million

VNDA Net Income

No data available :(

VNDA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 388.3 million - 9.4 million
2023-09-30 489.9 million - 7.5 million
2023-06-30 489.4 million - 7.9 million
2023-03-31 501.5 million - 10.7 million

VNDA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 57.5 million
2023-09-30 57.6 million
2023-06-30 57.5 million
2023-03-31 57.4 million

VNDA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 253000 24.3 million 23.6 million -
2023-09-30 24000 16.6 million 24.8 million -
2023-06-30 55000 16.6 million 28.4 million -
2023-03-31 51000 19.2 million 36.1 million -

VNDA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 45.3 million 3.5 million
2023-09-30 38.8 million 3.1 million
2023-06-30 46.1 million 3.5 million
2023-03-31 62.5 million 4.8 million

VNDA

Price: $4.68

52 week price:
3.30
7.00

Earnings Per Share: 0.04 USD

P/E Ratio: 16.52

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 456204

Ebitda: -1.4 million

Market Capitalization: 259.5 million

Links: